Tuberculosis Diagnostics Market Report 2023

Tuberculosis Diagnostics Global Market Report 2024 – By Test Type (Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types), By Disease Stage (Latent Tuberculosis, Active Tuberculosis), By End-User (Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount

Need assistance or more information before the purchase?

Enquire Before Buying
Tuberculosis Diagnostics Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Tuberculosis Diagnostics Market Definition And Segments

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for TB diagnosis and tracking the effectiveness of treatment. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

The various types of tuberculosis diagnostic markets include radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test or Mantoux test (TST), blood/serology test, smear microscopy tests, cell culture-based tests, and others. Radiographic tests are used to detect chest abnormalities in the case of tuberculosis symptoms. The radiographic test refers to the diagnosis of lesions that may develop anywhere in the lungs and vary in terms of cavitation, density, size, and shape. The tests include nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and others, used for disease stages such as latent tuberculosis and active tuberculosis. The end-users of tuberculosis diagnostics include hospitals and diagnostic laboratories, physician’s office laboratories, reference laboratories, academic institutions, and research facilities.

The tuberculosis diagnostics market covered in this report is segmented –

1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test or Mantoux Test (TST), Blood or Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types

2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis

3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities

The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.

The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.02 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.

Tuberculosis Diagnostics In Response To Rising Incidence

The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis is an infectious disease that affects the lungs and can be severe. Tuberculosis is spread through coughing and sneezing, releasing tiny germs into the air. Tuberculosis diagnostics aid in patient detection, with earlier diagnosis and detection of diseases. For instance, in March 2022, in the weekly report of the Centers for Disease Control and Prevention, a US-based national public health agency, tuberculosis infections in the United States increased by 9.4% in 2021, with a total of 7,860 TB cases were reported in 2021, an increase from 7,173 cases in 2020. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.

FDA Approvals Driving Growth In Tuberculosis Diagnostics Market

During the forecast period, the increasing US Food and Drug Administration (FDA) approvals for tuberculosis diagnostics will support the growth of the tuberculosis diagnostics market. For example, in March 2023, PerkinElmer Oxford Immunotec, a UK-based medical diagnostics company, announced that the US FDA has approved the use of two additional cell isolation instruments Auto-Pure 24 and Auto-Pure 20B platforms manufactured by Allsheng Instruments. Further, in October 2022, PerkinElmer Oxford Immunotec announced that the FDA has approved the use of the T-Cell Select reagent kit for the automation of its T-SPOT.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories. T-Cell Select is a peripheral blood mononuclear cell (PBMC) isolation reagent that uses positive selection of PBMCs with magnetic bead-based cell separation to automate and simplify the preparation of cells for the T-SPOT.TB test, a globally regulated ELISPOT IGRA for detecting latent TB infection. Therefore, the increasing approvals for new tuberculosis diagnostics will support the growth of the tuberculosis diagnostics market.

Major companies operating in the tuberculosis diagnostics market report are Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad Laboratories India Pvt. Ltd., Zhejiang Di'an Diagnostics Technology Co., Ltd., ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, Fresenius, Koninklijke Philips, Novartis, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Johnson & Johnson, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., Pfizer, Agilent Technologies Inc., AutoGenomics, AdvaCare Pharma, Akonni Biosystems Inc., Par Pharmaceutical, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Grifols S.A., Bio Certica, Biovac, BixBio

Tech Advancements Transforming Tuberculosis Diagnostics Market

Technological innovations are the key trend gaining popularity in the tuberculosis diagnostics market. Major companies operating in the market are introducing new technologies, such as advanced point-of-care (POC) diagnostic methods that work on AI technology to sustain their position in the market. For instance, in August 2022, Fujifilm, a Japan-based company engaged in the manufacturing of medical imaging devices, partnered with Qure.ai, a US-based company engaged in the development of AI-enabled medical imaging solutions, and launched an advanced point-of-care (POC) diagnostic method. A battery-powered X-ray machine is used in this method for tuberculosis diagnosis. With the help of artificial intelligence, algorithms help in effective testing programs, offering ultra-portability, high accuracy, and efficient point-of-care diagnostic solutions.

Product Innovations Driving Tuberculosis Diagnostics

Product innovations are a key trend in the tuberculosis diagnostics market, as companies look to stay competitive and meet the evolving needs and preferences of consumers. The innovation in a product can generate buzz and excitement, which can drive sales and increase brand awareness. Companies in the tuberculosis diagnostics market are focusing on product innovations and developing new product solutions to strengthen their position in the market. For example, in February 2023, Redcliffe Labs, an India-based technology-empowered diagnostics service provider, launched the BD MAX MDR TB (Tuberculosis) test, a diagnostic test to enable clinicians to rapidly test for tuberculosis and multidrug resistance as a first-line test, which is performed on BD MAX molecular diagnostic system. Clinicians use the test to simultaneously detect bacteria that cause TB and determine if the bacteria contain mutations associated with resistance to two important first-line drugs, Isoniazid (INH) and Rifampicin (RIF).

Acquisition Of Oxford Immunotec For Tuberculosis Diagnostics

In March 2021, PerkinElmer, a US-based company engaged in diagnostics and scientific research, acquired Oxford Immunotec for $591 million. With this acquisition, PerkinElmer would expand its offering of infectious disease testing solutions, including tuberculosis detection, to serve clients worldwide. Oxford Immunotec is a UK-based company engaged in developing and commercializing proprietary assays for immunology and infectious diseases.

Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2023. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The tuberculosis diagnostics market research report is one of a series of new reports from The Business Research Company that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tuberculosis Diagnostics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.27 billion
Revenue Forecast In 2033 $3.02 billion
Growth Rate CAGR of 7.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Techne India Private Limited; Bio-Rad laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co., Ltd; ADICON Clinical Laboratories; Guangzhou Kingmed Diagnostics Center Co. Ltd.; Kindstar Global; OriGene Technologies; Siemens AG; Fresenius; Koninklijke Philips; Novartis; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Bayer AG; Cantel Medical Corporation; Meridian Bioscience; Johnson & Johnson; Abbott laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Pfizer; Agilent technologies Inc; AutoGenomics; AdvaCare Pharma; Akonni Biosystems Inc; Par Pharmaceutical; Epistem Limited; Gen-Probe; Sysmex South Africa (Pty) Ltd.; Grifols S.A.; Bio Certica; Biovac; BixBio
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Tuberculosis Diagnostics Market Characteristics

    3. Tuberculosis Diagnostics Market Trends And Strategies

    4. Tuberculosis Diagnostics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Tuberculosis Diagnostics Market Size and Growth

    5.1. Global Tuberculosis Diagnostics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Tuberculosis Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Tuberculosis Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Tuberculosis Diagnostics Market Segmentation

    6.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Radiographic Tests

    Nucleic Acid Testing

    Cytokine Detection Tests

    Drug Resistance Tests

    Skin Test / Mantoux Test (TST)

    Blood/Serology Test

    Smear Microscopy Tests

    Cell Culture-Based Tests

    Other Test Types

    6.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Latent Tuberculosis

    Active Tuberculosis

    6.3. Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Diagnostic Laboratories

    Physician’s Office Laboratories

    Reference Laboratories

    Academics And Research Facilities

    7. Tuberculosis Diagnostics Market Regional And Country Analysis

    7.1. Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Tuberculosis Diagnostics Market

    8.1. Asia-Pacific Tuberculosis Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Tuberculosis Diagnostics Market

    9.1. China Tuberculosis Diagnostics Market Overview

    9.2. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Tuberculosis Diagnostics Market

    10.1. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Tuberculosis Diagnostics Market

    11.1. Japan Tuberculosis Diagnostics Market Overview

    11.2. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Tuberculosis Diagnostics Market

    12.1. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Tuberculosis Diagnostics Market

    13.1. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Tuberculosis Diagnostics Market

    14.1. South Korea Tuberculosis Diagnostics Market Overview

    14.2. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Tuberculosis Diagnostics Market

    15.1. Western Europe Tuberculosis Diagnostics Market Overview

    15.2. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Tuberculosis Diagnostics Market

    16.1. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Tuberculosis Diagnostics Market

    17.1. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Tuberculosis Diagnostics Market

    18.1. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Tuberculosis Diagnostics Market

    19.1. Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Tuberculosis Diagnostics Market

    20.1. Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Tuberculosis Diagnostics Market

    21.1. Eastern Europe Tuberculosis Diagnostics Market Overview

    21.2. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Tuberculosis Diagnostics Market

    22.1. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Tuberculosis Diagnostics Market

    23.1. North America Tuberculosis Diagnostics Market Overview

    23.2. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Tuberculosis Diagnostics Market

    24.1. USA Tuberculosis Diagnostics Market Overview

    24.2. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Tuberculosis Diagnostics Market

    25.1. Canada Tuberculosis Diagnostics Market Overview

    25.2. Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Tuberculosis Diagnostics Market

    26.1. South America Tuberculosis Diagnostics Market Overview

    26.2. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Tuberculosis Diagnostics Market

    27.1. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Tuberculosis Diagnostics Market

    28.1. Middle East Tuberculosis Diagnostics Market Overview

    28.2. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Tuberculosis Diagnostics Market

    29.1. Africa Tuberculosis Diagnostics Market Overview

    29.2. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Tuberculosis Diagnostics Market Competitive Landscape And Company Profiles

    30.1. Tuberculosis Diagnostics Market Competitive Landscape

    30.2. Tuberculosis Diagnostics Market Company Profiles

    30.2.1. Beckton, Dickinson and Company

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. F. Hoffmann-La Roche Ltd

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Qiagen N.V

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. BioMerieux SA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Danaher Corporation

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Tuberculosis Diagnostics Market Other Major And Innovative Companies

    31.1. PerkinElmer

    31.2. Thermo Fisher Scientific Inc.

    31.3. Creative Diagnostics

    31.4. Lionex GmbH

    31.5. Biocartis

    31.6. Bio-Techne India Private Limited

    31.7. Bio-Rad laboratories India Pvt.Ltd

    31.8. Zhejiang Di'an Diagnostics Technology Co., Ltd

    31.9. ADICON Clinical Laboratories

    31.10. Guangzhou Kingmed Diagnostics Center Co. Ltd.

    31.11. Kindstar Global

    31.12. OriGene Technologies

    31.13. Siemens AG

    31.14. Fresenius

    31.15. Koninklijke Philips

    32. Global Tuberculosis Diagnostics Market Competitive Benchmarking

    33. Global Tuberculosis Diagnostics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Tuberculosis Diagnostics Market

    35. Tuberculosis Diagnostics Market Future Outlook and Potential Analysis

    35.1 Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Tuberculosis Diagnostics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Beckton, Dickinson and Company Financial Performance
  • Table 75: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 76: Qiagen N.V Financial Performance
  • Table 77: BioMerieux SA Financial Performance
  • Table 78: Danaher Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Tuberculosis Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Tuberculosis Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Tuberculosis Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Beckton, Dickinson and Company Financial Performance
  • Figure 75: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 76: Qiagen N.V Financial Performance
  • Figure 77: BioMerieux SA Financial Performance
  • Figure 78: Danaher Corporation Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Respiratory Disposables Global Market Report 2024 – By Type (Masks, Tubes, Inhalers, Other Types), By Disease Indications (Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, Other Chronic Respiratory Diseases), By Application (Adult, Pediatric & Neonatal), By End User (Hospitals, Clinics, Ambulatory Care Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024 – By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers), By Technology (HEPA Filter, Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, Other Technologies), By End-User (Homecare settings, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Transplant Diagnostics Global Market Report 2024 – By Type (Reagent & Consumables, Instrument, Software & Services), By Transplant Type (Solid Organ, Stem Cell), By Organ (Kidney, Liver, Heart, Lung, Pancreas), By Technology (Non Molecular Assay, Molecular Assay), By End User (Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Transfusion Diagnostics Global Market Report 2024 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Molecular Diagnostics Devices And Equipment Global Market Report 2024 – By Product (Instruments, Reagents And Consumables, Software), By Technology (DNA (Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications), By End User (Diagnostic laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Molecular Diagnostics Global Market Report 2022 – By Technology (Polymerase Chain Reaction (PCR), DNA Sequencing, and Next-Generation Sequencing), By Product (Instruments, Reagents and Consumables, Software and Services), By Application (Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, and Other Applications), By End-User (Hospitals, Laboratories, and Other End-Users (Blood Banks, Home Health Agencies, and Nursing Homes) – Market Size, Trends, And Global Forecast 2022-2026
View Report